Trials / Unknown
UnknownNCT01816191
An Open-Label, Single- and Multi-Dose Pharmacokinetic (PK) Study of Oral Diltiazem and Topical Diltiazem Hydrochloride
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- Ventrus Biosciences, Inc · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The study is a single-center, open-label, safety and pharmacokinetic study in12 adult subjects with Anal Fissures. Subjects will be screened to determine eligibility within 7 days of treatment. There will be three parts to the study and all subjects will participate in each part.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Diltiazem Hydrochloride Cream and Oral Diltiazem |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2013-07-01
- Completion
- 2013-09-01
- First posted
- 2013-03-22
- Last updated
- 2013-08-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01816191. Inclusion in this directory is not an endorsement.